The Patent Finder

Terms ending in 2039

Genzyme Corporation

Every in-force patent on Genzyme Corporation's record whose computed term ends in 2039, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 10,900,972Methods for Absolute Quantification of Low-Abundance Polypeptides Using Mass Spectrometry
In force
 · High confidence
Genzyme CorporationIn forceHigh confidence
US 11,835,434Methods for Absolute Quantification of Low-Abundance Polypeptides Using Mass Spectrometry
In force
 · High confidence
Genzyme CorporationIn forceHigh confidence
US 12,073,924Multivariate Spectral Analysis and Monitoring for Biomanufacturing
In force
 · High confidence
Genzyme CorporationIn forceHigh confidence
US 11,434,464Perfusion Bioreactor With Filtration Systems
In force
 · High confidence
Genzyme CorporationIn forceHigh confidence
US 12,110,483Perfusion Bioreactor With Filtration Systems
In force
 · Medium confidence
Genzyme CorporationIn forceMedium confidence
US 11,754,573Methods for the Quantitation of Polypeptides
In force
 · High confidence
Genzyme CorporationIn forceHigh confidence
US 12,331,296VARIANT RNAi
In force
 · High confidence
Genzyme CorporationIn forceHigh confidence
US 11,685,943Early Post-Transfection Isolation of Cells (EPIC) for Biologics Production
In force
 · High confidence
Genzyme CorporationIn forceHigh confidence
US 11,098,056Udp Glycosyltransferase Inhibitors and Methods of Use
In force
 · High confidence
Genzyme CorporationIn forceHigh confidence
US 11,067,584Methods for the Quantitation of Polypeptides
In force
 · High confidence
Genzyme CorporationIn forceHigh confidence
2 more term ends in 2039 · Pro
10 of 12 patents shown. Soonest term end first, then patent number.
Pro members see all 12.
Upgrade to Pro
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited